LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
BCIQ Data Coverage
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
3rd Biotech CEO & Investor Reception
East-West Biopharma Summit 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Huazhong University of Science and Technology
Headquarters:
Wuhan, China
Website:
http://english.hust.edu.cn
Year Founded:
1907
Status:
N/A
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Sep 19, 2025
Distillery Therapeutics
Inhibiting SLC38A2 for hypertension
Read More
BioCentury
|
Sep 19, 2025
Distillery Therapeutics
Inhibiting ABCC4 for rheumatoid arthritis
Read More
BioCentury
|
Dec 16, 2024
Distillery Therapeutics
Inhibiting macrophage PDIA3 activity for obesity
Read More
BioCentury
|
Sep 6, 2024
Distillery Therapeutics
Peptide blockade of YTHDF3 palmitoylation for pancreatic cancer
Read More
BioCentury
|
Sep 14, 2023
Distillery Therapeutics
Strategies to inhibit KIM1-mediated cell death for acute kidney injury
Read More
BioCentury
|
Mar 8, 2023
Distillery Therapeutics
AT3 gene editing in iPSCs for hereditary thrombophilia
Read More
BioCentury
|
Dec 7, 2022
Distillery Therapeutics
DNA-scavenging nanoparticles for periodontitis
Read More
BioCentury
|
Oct 1, 2022
Discovery & Translation
An anti-IgE protein-bacteria combo for food allergy; predicting COVID mutants, Lasker winners and more
BioCentury’s roundup of translational news
Read More
BioCentury
|
Jun 26, 2020
Distillery Therapeutics
MAP3K7, IL18R1 as targets in obesity-related cerebrovascular dysfunction
Read More
BioCentury
|
May 15, 2020
Translation in Brief
Passage’s mouse, dog data for Krabbe disease; plus a predictive model of COVID-19 mortality, Sorrento’s COVID-19 antibody candidate and more
BioCentury’s roundup of preclinical news
Read More
Items per page:
10
1 - 10 of 27